Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence : Part I—Lymphoma
✍ Scribed by Carolyn Featherstone; Geoff Delaney; Susannah Jacob; Michael Barton
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 237 KB
- Volume
- 103
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND Radiotherapy is not used commonly in the treatment of patients with malignant melanoma. The benchmark optimal radiotherapy utilization rates for melanoma are largely unknown, despite the fact that melanoma is a very common cancer. ## METHODS To develop an evidence‐based
## Abstract ## BACKGROUND Radiotherapy utilization rates for breast carcinoma vary widely, both within and between countries. Current estimates of the proportion of patients with carcinoma who optimally should receive radiotherapy are based either on expert opinion or on the measurement of actual
## Abstract ## BACKGROUND Radiotherapy utilization rates for cancer vary widely, both within and between countries. The optimal proportion of patients with gastrointestinal malignancies who should receive at least one course of radiotherapy at some time during their illness is an important benchma
## Abstract ## BACKGROUND Radiotherapy usage rates exhibit wide variations both within and between countries. Current estimates of the proportion of cancer patients who should optimally receive radiotherapy are based either on expert opinion or on the measurement of actual usage rates rather than
## Abstract Radiotherapy utilization rates for cancer vary widely internationally. It has previously been suggested that approximately 50% of all cancer patients should receive radiation. However, this estimate was not evidence‐based. The aim of this study was to estimate the ideal proportion of ne